Delivery Order SPE2DB24D2013-SPE2DB24FCHNT

Award Date 9/4/24
Potential Completion Date 9/25/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,311.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of ESBRIET 801 MG TABLET 90S, which are likely a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024. AmerisourceBergen is a major pharmaceutical distributor in the United States and has been awarded numerous federal contracts by defense and civilian agencies to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,311.50 contract is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, to support military treatment programs and facilities. The contract has a completion date of February 7, 2024 and was awarded on January 17, 2024....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ESBRIET 801 MG TABLET 90S, with a potential value of $3,311.50 and a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor providing pharmaceutical products and services to U.S. government agencies, primarily the Department of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product ESBRIET 801 MG TABLET 90S, with a potential value of $3,311.50 and a completion date of January 11, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a potential value of $9,934.50 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards to supply...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a potential value of $3,311.50 and a completion date of February 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ESBRIET 801 MG TABLET 90S. The award is valued at $3,311.50 and has a firm fixed price pricing type. The contract is not set aside and has an ultimate completion date of September 20, 2024. AmerisourceBergen provides pharmaceutical and medical supplies to support various government agencies and healthcare programs, including military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $3,425.95, is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price contract with a performance period ending on March 3, 2025. The award date was February 7, 2025, and there was no set-aside designation used. AmerisourceBergen Drug Corp is the prime contractor,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $3,311.50 order is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a completion date of February 13, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has an extensive history of providing...
This is a delivery order awarded by the Department of Defense's Medical Supply Chain (VPDLATSMED-A) to AmerisourceBergen Drug Corp's Corporate Office Division, a subsidiary of AmerisourceBergen Corporation, one of the largest pharmaceutical distribution companies worldwide. The $3,311.50 firm-fixed-price contract is for the delivery of 4564450688 - ESBRIET 801 MG TABLET 90S, with a completion date of May 21, 2024. The award is not associated with a set-aside program. AmerisourceBergen Drug...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB24FCHNT
    Delivery Order

This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $3,311.50, is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has a completion date of September 25, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of the company's extensive federal contracting activities. The contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and there are no subcontractors mentioned. The DLA is the funding agency, and this award supports the agency's mission of providing medical commodities to military treatment programs and facilities worldwide.

Generated 12/4/24, 9:10 AM